this notification is the only thing holding us back. soon

New Post Public Reply Private Reply Replies (0) Message Board
Frewil
534
this notification is the only thing holding us back. soon as we get the 10q. we should see a little pop. it always moves on the Q's and K's

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Source: Edgar (US Regulatory)
 

 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 12b-25
 
NOTIFICATION OF LATE FILING
 
[  ] Form 10-K[  ] Form 20-F[  ] Form 11-K[X  ] Form 10-Q[  ] Form 10-D[  ] Form N-SAR[  ] Form N-CSR 
 
For Period Ended: September 30, 2020
 
[  ] Transition Report on Form 10-K[  ] Transition Report on Form 10-Q[  ] Transition Report on Form 20-F[  ] Transition Report on Form 11-K[  ] Transition Report on Form N-SAR 
 
For the Transition Period Ended: _______________________________________
 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
 
PART I
REGISTRANT INFORMATION
 
Full name of registrant: eWellness Healthcare Corporation   Former name if applicable:     Address of principal executive office: 
1126 S Federal Hwy #464
   City, state and zip code 
Fort Lauderdale, FL 33316
 

 

 

   

 

 
PART II 
RULES 12b-25 (b) AND (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
 
[X]The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;  [X]The subject annual report, semi-annual report, transition report on Forms 10-K, 20-F, 11-K, N-SAR, or N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and an accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
PART III
NARRATIVE
 
State below in reasonable detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.
 
The Registrant is currently in the process of completing the process of compiling and disseminating the information required to be included in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 as well as the required review of the Registrant’s financial information. The Registrant is not able to complete the process without incurring undue hardship and expense. The Registrant will require additional time to complete and file its Form 10-Q for the quarter ended September 30, 2020 and plans to file it by November 23, 2020.
 
PART IV 
OTHER INFORMATION
 
(1) Name and telephone number of person to contact in regard to this notification
 
Douglas MacLellan
 (310) 283-4201(Name) (Area Code) (Telephone Number)
 
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
 
[X] Yes [  ] No
 
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
 
[  ] Yes [X] No
 
If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 

   

 

 
eWellness Healthcare Corporation
Name of Registrant as Specified in Charter.
 
Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
 
 eWellness Healthcare Corporation   
November 16, 2020
By:
/s/ Douglas MacLellan
  
Douglas MacLellan
  Chief Executive Officer
 

   

 
 
 
#ewll
#frewil

eWellness Healthcare Corp (EWLL) Stock Research Links

EWLL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Svitzer Group Announces Major Shareholder Notification

Updated Category News Views 258

Major Shareholder Notification from Morgan Stanley In accordance with the Danish Capital Markets Act, Svitzer Group A/S, recognized by CVR-no. 44 79 14 47, shares an important notification regarding its major shareholder. Morgan Stanley recently disclosed that as of a specified date, it directly or indirectly holds 1,642,654 shares in Svitzer Group. This corresponds to...

Continue Reading
Petco Health and Wellness Faces Legal Action: Key Investor Insights

Updated Category News Views 93

Understanding Petco Health and Wellness Legal Challenges Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) has recently encountered significant legal challenges that may impact its investors. As a notable player in the pet health and wellness sector, Petco is dedicated to improving the lives of pets and their owners. However, the company is currently under scrutiny...

Continue Reading
Survey Shows Users Favor Unrestricted AI Interaction

Updated Category News Views 116

Survey Reveals User Preferences for AI Interaction A recent survey conducted by Muah AI has shed light on user preferences, revealing a strong inclination towards uncensored large language models (LLMs). More than 85% of the 25,000 active respondents expressed a desire for less restrictive communication tools. This finding indicates a growing demand for more open and...

Continue Reading
Dyne Therapeutics Set to Shine at Upcoming Research Conference

Updated Category News Views 224

Dyne Therapeutics Announces Presentations at Major Conference Dyne Therapeutics, Inc (NASDAQ: DYN), primarily known for its dedication to advancing therapeutics for neuromuscular diseases, is gearing up to showcase its innovative research at the upcoming MDA Clinical & Scientific Conference. This event is scheduled to take place from March 16-19, 2025, and will feature a...

Continue Reading
Uniting Forces Against Illegal Trade for National Prosperity

Updated Category News Views 147

Strengthening the Fight Against Illegal Trade Public and private sector security experts have gathered to address the escalating threat of illegal trade and its impact on American society. Over 75 leaders recently met at the USA-IT 2025 National Summit to call on Congress for new policies aimed at dismantling the $2.2 trillion underground economy, which encompasses...

Continue Reading